rapid automated multiplex pcr diagnostics for blood pathogens

1
Presented at the 112 th General Meeting of the American Society for Microbiology, June 2012 Minor revisions have been made to this poster since its presentation at ASM (June 2012). CONTACT INFORMATION Andrew Hemmert, Ph.D. Idaho Technology, Inc. [email protected] I. Ota 1 , E. Barker 1 , A. Hemmert 1 , B. Baarda 1 , O. Cham 1 , C. Heyrend 1 , B. Barrett 1 , N. Garrone 1 , S. Thatcher 1 , R. Crisp 1 , P. Lephart 5 , S. Silbert 6 , C. Kubasek 6 , A. Blaschke 3 , J. Daly 2 , H. Salimnia 4 , R. Widen 6 , & K. Ririe 1 1 Idaho Technology, Inc. (ITI), 2 Primary Children’s Medical Center (PCMC), 3 University of Utah (UU), 4 Detroit Medical Center University Laboratories (DMCUL), 5 Wayne State University School of Medicine (WSUSM), 6 Tampa General Hospital Clinical Laboratory (TGH) Rapid Automated Multiplex PCR Diagnostics for Blood Pathogens On-Site Testing in Clinical Microbiology Laboratories CONCLUSION • The FilmArray BCID exhibited high sensitivity and specificity for all organisms and antibiotic resistance genes when compared to conventional culture methods. • Low prevalence organisms will be evaluated at ITI to confirm sensitivity and specificity. FilmArray BCID is currently being evaluated for 510k FDA clearance. UPDATED ABSTRACT Rapid identification of the numerous organisms causing sepsis, and identification of antimicrobial resistance genes could improve patient outcomes. The ITI FilmArray ® , which streamlines pathogen identification and provides results in ~1 h would facilitate this process. The FilmArray comprises a unique lab-in-a-pouch and countertop instrument which automatically extracts nucleic acids, performs nested multiplex PCR and data analysis. We describe results from beta testing of the development version of the FilmArray Blood Culture Identification (BCID) system, which aims to detect ~ 90% of pathogens isolated from positive aerobic blood cultures (PABCs) and select antibiotic resistance genes. PABCs from children and adults were tested using IRB approved protocols in FilmArray BCID pouches at three sites, PCMC, DMCUL and TGH, and compared to conventional blood culture and susceptibility testing. An aliquot of PABC (250 µL) was simultaneously tested in a BCID pouch with nested multiplexed PCR assays for gram positive and negative bacteria, antibiotic resistance genes, and fungi. A total of 403 blood cultures were tested by FilmArray BCID. Conventional culture identified 467 pathogens; the FilmArray contained assays to detect 430 of them. Of these 430 pathogens, 386 (90%) were identified by the FilmArray. System sensitivity (true positives/ the sum of true positives and false negatives), was 95% or greater for most organisms including Staphylococcus aureus, Streptococcus, Enterococcus, Enterobacteriaceae, Pseudomonas aeruginosa and Candida species. For antibiotic resistance genes greater than 95% sensitivity was obtained. System specificity (true negatives/ the sum of true negatives and false positives) was equally good with 95% or greater specificity for nearly all tests. UPDATE During a second round of beta testing (data shown in center), 130 PABCs were tested using the FilmArray BCID panel (DMCUL). Conventional culture identified 137 pathogens; the FilmArray contained assays to detect 128. Of these 128, 122 (95.3%) were identified correctly by the FilmArray. The FilmArray BCID system demonstrated accurate identification of pathogens and antibiotic resistance genes in PABC samples. Rapid identification of a large range of pathogens in blood culture could improve the medical management of sepsis. INTRODUCTION Rapid identification of the numerous organisms causing sepsis and identification of antimicrobial resistance genes could improve patient outcomes. The ITI FilmArray, which streamlines pathogen identification, providing results in ~ 1 hr, would facilitate this process. We describe results from beta testing of the development version of the FilmArray BCID system which aims to detect ~90% of pathogens isolated from PABC samples and select antibiotic resistance genes. FilmArray BCID Panel Gram Positive Bacteria Staphylococcus species Staphylococcus aureus Coagulase negative Staphylococci Enterococcus species Listeria monocytogenes Streptococcus species Streptococcus agalactiae Streptococcus pneumoniae Streptococcus pyogenes Viridans Streptococci Gram Negative Bacteria Acinetobacter baumannii Enterobacteriaceae family: Citrobacter Enterobacter Enterobacter cloacae Escherichia Escherichia coli Klebsiella Klebsiella oxytoca Klebsiella pneumoniae Salmonella Shigella Serratia Proteus Haemophilus influenzae Neisseria meningitidis Pseudomonas aeruginosa Antibiotic resistance genes mecA gene KPC gene vanA gene vanB gene Fungi Candida albicans Candida glabrata Candida krusei Candida parapsilosis Candida tropicalis Clinical Beta Testing Results Gram Positive Bacteria TP FN Sensitivity TN FP Specificity Enterococcus 50 1 98.0% 474 8 98.3% S. aureus 76 2 97.4% 454 1 99.8% Staphylococcus* 61 3 95.3% 62 4 93.9% S. agalactiae 6 1 85.7% 526 0 100.0% S. pneumoniae 6 0 100.0% 526 1 99.8% S. pyogenes 7 0 100.0% 526 0 100.0% Streptococcus 58 4 93.5% 462 9 98.1% Gram Negative Bacteria TP FN Sensitivity TN FP Specificity A. baumannii 8 0 100.0% 523 2 99.6% E. cloacae* 6 1 85.7% 123 0 100.0% Enteric 114 1 99.1% 412 6 98.6% E. coli 61 1 98.4% 463 8 98.3% H. influenzae 1 0 100.0% 530 2 99.6% K. oxytoca 2 0 100.0% 527 4 99.2% K. pneumoniae* 8 0 100.0% 122 0 100.0% L. monocytogenes* 0 0 0.00% 533 0 100.0% N. meningitidis 1 0 100.0% 532 0 100.0% Proteus* 4 0 100.0% 125 1 99.2% P. aeruginosa 17 1 94.4% 506 9 98.3% Serratia 4 0 100.0% 528 1 99.8% Fungi TP FN Sensitivity TN FP Specificity C. albicans 14 0 100.0% 517 2 99.6% C. glabrata 8 0 100.0% 525 0 100.0% C. krusei 3 0 100.0% 530 0 100.0% C. parapsilosis 10 0 100.0% 522 1 99.8% C. tropicalis 4 0 100.0% 528 1 99.8% Antibiotic Resistance Genes TP FN Sensitivity TN FP Specificity KPC 2 0 100.0% 531 0 100.0% mecA* 46 1 97.9% 73 10 88.0% vanA/B 14 0 100.0% 519 0 100.0% *Due to significant assay/protocol changes, only the second round of beta data is shown. ACKNOWLEDGEMENTS Development of the FilmArray BCID panel is supported by grant number U01 AI082184 from the NIAID, NIH. Special thanks to all those who provided samples for preliminary testing: ARUP, Salt Lake City, UT Dr. Judy Daly, Primary Children’s Medical Center Dr. Hossein Salimnia, Detroit Medical Center University Laboratories Dr. Raymond H. Widen, Tampa General Hospital Clinical Laboratory 1239 Figure 1 A. Fitment with freeze-dried reagents B. Plungers- deliver reagents to blisters C. Sample lysis and bead collection D. Wash station E. Magnetic bead collection blister F. Elution Station G. Multiplex Outer PCR blister H. Dilution blister I. Inner Nested PCR array ITI has developed a lab-in-a-pouch system called “FilmArray”. It is a medium-scale fluid manipu- lation system performed in a self-contained, disposable, thin-film plastic pouch. The FilmArray platform processes a single sample, from nucleic acid purification to result, in a fully automated fashion. These system characteristics are ideal for the multiplex testing of pathogens in standard diagnostic sample matrices. The FilmArray Test System A FilmArray test is initiated by injecting re- hydration solution and a patient sample into the FilmArray pouch and placing it in the FilmArray instrument. The user enters the sample and pouch type (using a barcode reader) into the software and initiates a run. Results are provided in ~ 1 hour. The film portion of the pouch has stations for: 1. Cell lysis (Blister C) 2. Magnetic-bead based nucleic acid purification (D & E) 3. First-stage multiplex PCR (F & G) 4. Array of 102, second-stage nested PCRs (I) C D E F G I Figure 2A Figure 2C Melt curve analysis data for a positive blood culture sample: DMCUL identified this sample to be positive for K. pneumoniae which contained KPC. FilmArray correctly identified the organism and the antibiotic resistance gene it contained. Blue = KPC assay Pink = K. pneumoniae assay Purple = Enteric assay Melt curve analysis data for a Pseudomonas aeruginosa PABC sample from PCMC. Figure 2B Melt curve analysis data for a Staphylococcus aureus (mecA+) and Group A Streptococcus co-infection from TGH. Red = mecA assay Green = S. aureus assay Pink = S. pyogenes assay Grey = Streptococcus assay See all of ITI’s scientific posters by scanning the QR code to access the Scientific Poster Page METHODS PABC samples from children and adults from three different sites (PCMC, DMCUL and TGH) were tested using IRB approved protocols in a FilmArray BCID pouch. FilmArray results were compared to conventional blood culture and susceptibility testing. One 250 µl aliquot from each PABC was simultaneously tested in a pouch with nested multiplexed PCR assays for gram positive and gram negative bacteria, fungi and antibiotic resistance genes. PCR primers are dried into the wells of the array and each primer set amplifies a unique product of the first-stage multiplex PCR. The second stage PCR product is detected in real-time using a fluorescent-double-stranded DNA binding dye, LCGreen ® Plus.

Upload: truongdan

Post on 16-Dec-2016

230 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Rapid Automated Multiplex PCR Diagnostics for Blood Pathogens

Presented at the 112th General Meeting of the American Society for Microbiology, June 2012Minor revisions have been made to this poster since its presentation at ASM (June 2012).

CONTACT INFORMATIONAndrew Hemmert, Ph.D.Idaho Technology, [email protected]

I. Ota1, E. Barker1, A. Hemmert1, B. Baarda1, O. Cham1, C. Heyrend1, B. Barrett1, N. Garrone1, S. Thatcher1, R. Crisp1, P. Lephart5, S. Silbert6, C. Kubasek6, A. Blaschke3, J. Daly2, H. Salimnia4, R. Widen6, & K. Ririe1

1Idaho Technology, Inc. (ITI), 2Primary Children’s Medical Center (PCMC), 3University of Utah (UU), 4Detroit Medical Center University Laboratories (DMCUL), 5Wayne State University School of Medicine (WSUSM), 6Tampa General Hospital Clinical Laboratory (TGH)

Rapid Automated Multiplex PCR Diagnostics for Blood Pathogens On-Site Testing in Clinical Microbiology Laboratories

CONCLUSION• The FilmArrayBCID exhibited high sensitivity and specificity for all organisms and

antibiotic resistance genes when compared to conventional culture methods.

• LowprevalenceorganismswillbeevaluatedatITItoconfirmsensitivityandspecificity.

• FilmArray BCID is currently being evaluated for 510k FDA clearance.

UPDATED ABSTRACTRapid identification of the numerous organisms causing sepsis, and identification ofantimicrobial resistance genes could improve patient outcomes. The ITI FilmArray®, whichstreamlinespathogenidentificationandprovidesresultsin~1hwouldfacilitatethisprocess. The FilmArray comprises a unique lab-in-a-pouch and countertop instrument which automatically extracts nucleic acids, performs nested multiplex PCR and data analysis. We describe results from beta testing of the development version of the FilmArray BloodCulture Identification(BCID)system,whichaimstodetect~90%ofpathogensisolated from positive aerobic blood cultures (PABCs) and select antibiotic resistance genes.

PABCs from children and adults were tested using IRB approved protocols in FilmArray BCID pouches at three sites, PCMC, DMCUL and TGH, and compared to conventional blood culture and susceptibility testing. An aliquot of PABC (250 µL) was simultaneously tested in a BCID pouch with nested multiplexed PCR assays for gram positive and negative bacteria, antibiotic resistance genes, and fungi.

Atotalof403bloodculturesweretestedbyFilmArrayBCID.Conventionalcultureidentified467 pathogens; the FilmArray contained assays to detect 430 of them. Of these 430 pathogens,386(90%)wereidentifiedbytheFilmArray.Systemsensitivity(truepositives/thesumoftruepositivesandfalsenegatives),was95%orgreaterformostorganismsincluding Staphylococcus aureus, Streptococcus, Enterococcus, Enterobacteriaceae, Pseudomonas aeruginosa and Candida species. For antibiotic resistance genes greater than95%sensitivitywasobtained.Systemspecificity(truenegatives/thesumoftruenegativesandfalsepositives)wasequallygoodwith95%orgreaterspecificityfornearlyall tests.

UPDATEDuring a second round of beta testing (data shown in center), 130 PABCs were tested usingtheFilmArrayBCIDpanel(DMCUL).Conventionalcultureidentified137pathogens;theFilmArraycontainedassaystodetect128.Ofthese128,122(95.3%)wereidentifiedcorrectly by the FilmArray.

The FilmArray BCID system demonstrated accurate identification of pathogens andantibiotic resistancegenes inPABCsamples.Rapid identificationofa large rangeofpathogens in blood culture could improve the medical management of sepsis.

INTRODUCTIONRapid identification of the numerous organisms causing sepsis and identification ofantimicrobial resistance genes could improve patient outcomes. The ITI FilmArray, which streamlinespathogenidentification,providingresultsin~1hr,wouldfacilitatethisprocess.We describe results from beta testing of the development version of the FilmArray BCID systemwhichaimstodetect~90%ofpathogensisolatedfromPABCsamplesandselectantibiotic resistance genes.

FilmArray BCID Panel

Gram Positive Bacteria Staphylococcus species• Staphylococcus aureus• Coagulase negative

StaphylococciEnterococcus speciesListeria monocytogenesStreptococcus species• Streptococcus agalactiae

• Streptococcus pneumoniae

• Streptococcus pyogenes• Viridans Streptococci

Gram Negative BacteriaAcinetobacter baumanniiEnterobacteriaceae family:• Citrobacter

• Enterobacter• Enterobacter cloacae

• Escherichia• Escherichia coli

• Klebsiella• Klebsiella oxytoca• Klebsiella pneumoniae

• Salmonella• Shigella

• Serratia• Proteus HaemophilusinfluenzaeNeisseria meningitidisPseudomonas aeruginosa

Antibiotic resistance genesmecA geneKPC gene

vanA genevanB gene

FungiCandida albicansCandida glabrataCandida kruseiCandida parapsilosisCandida tropicalis

Clinical Beta Testing Results

Gram Positive Bacteria

TP FN Sensitivity TN FP Specificity

Enterococcus 50 1 98.0% 474 8 98.3%S. aureus 76 2 97.4% 454 1 99.8%Staphylococcus* 61 3 95.3% 62 4 93.9%S. agalactiae 6 1 85.7% 526 0 100.0%S. pneumoniae 6 0 100.0% 526 1 99.8%S. pyogenes 7 0 100.0% 526 0 100.0%Streptococcus 58 4 93.5% 462 9 98.1%

Gram Negative Bacteria

TP FN Sensitivity TN FP Specificity

A. baumannii 8 0 100.0% 523 2 99.6%E. cloacae* 6 1 85.7% 123 0 100.0%Enteric 114 1 99.1% 412 6 98.6%E. coli 61 1 98.4% 463 8 98.3%H.influenzae 1 0 100.0% 530 2 99.6%K. oxytoca 2 0 100.0% 527 4 99.2%K. pneumoniae* 8 0 100.0% 122 0 100.0%

L. monocytogenes* 0 0 0.00% 533 0 100.0%

N. meningitidis 1 0 100.0% 532 0 100.0%

Proteus* 4 0 100.0% 125 1 99.2%

P. aeruginosa 17 1 94.4% 506 9 98.3%

Serratia 4 0 100.0% 528 1 99.8%

Fungi

TP FN Sensitivity TN FP Specificity

C. albicans 14 0 100.0% 517 2 99.6%C. glabrata 8 0 100.0% 525 0 100.0%C. krusei 3 0 100.0% 530 0 100.0%C. parapsilosis 10 0 100.0% 522 1 99.8%C. tropicalis 4 0 100.0% 528 1 99.8%

Antibiotic Resistance Genes

TP FN Sensitivity TN FP Specificity

KPC 2 0 100.0% 531 0 100.0%mecA* 46 1 97.9% 73 10 88.0%vanA/B 14 0 100.0% 519 0 100.0%*Duetosignificantassay/protocolchanges,onlythesecondroundofbetadataisshown.

ACKNOWLEDGEMENTS• Development of the FilmArray BCID panel is supported by grant number U01 AI082184 from the

NIAID, NIH.• Special thanks to all those who provided samples for preliminary testing:

• ARUP, Salt Lake City, UT• Dr. Judy Daly, Primary Children’s Medical Center• Dr. Hossein Salimnia, Detroit Medical Center University Laboratories • Dr. Raymond H. Widen, Tampa General Hospital Clinical Laboratory

1239

Figure 1

A. Fitment with freeze-dried reagentsB. Plungers- deliver reagents to blistersC. Sample lysis and bead collectionD. Wash stationE. Magnetic bead collection blisterF. Elution StationG. Multiplex Outer PCR blisterH. Dilution blisterI. Inner Nested PCR array

ITIhasdevelopedalab-in-a-pouchsystemcalled“FilmArray”.Itisamedium-scalefluidmanipu-lationsystemperformed inaself-contained,disposable, thin-filmplasticpouch.TheFilmArrayplatformprocessesasinglesample,fromnucleicacidpurificationtoresult,inafullyautomatedfashion. These system characteristics are ideal for the multiplex testing of pathogens in standard diagnostic sample matrices.

The FilmArray Test SystemA FilmArray test is initiated by injecting re-hydration solution and a patient sample into the FilmArray pouch and placing it in the FilmArray instrument. The user enters the sample and pouch type (using a barcode reader) into the software and initiatesarun.Resultsareprovidedin~1hour.

Thefilmportionofthepouchhasstationsfor:

1. Cell lysis (Blister C)2. Magnetic-bead based nucleic acid purification(D&E)3. First-stagemultiplexPCR(F&G)4. Array of 102, second-stage nested

PCRs (I)

C D

E

F

G

I

Figure 2A

Figure 2C

Melt curve analysis data for a positive blood culture sample:DMCULidentifiedthissampletobepositivefor K. pneumoniae which contained KPC. FilmArray correctly identified the organism and the antibioticresistance gene it contained.

Blue = KPC assayPink = K. pneumoniae assayPurple = Enteric assay

Melt curve analysis data for a Pseudomonas aeruginosa PABC sample from PCMC.

Figure 2B

Melt curve analysis data for a Staphylococcus aureus (mecA+) and Group A Streptococcus co-infection from TGH.

Red = mecA assayGreen = S. aureus assayPink = S. pyogenes assay Grey = Streptococcus assay

SeeallofITI’sscientificposters by scanning the QR code to access the ScientificPosterPage

METHODSPABC samples from children and adults from three different sites (PCMC, DMCUL and TGH) were tested using IRB approved protocols in a FilmArray BCID pouch. FilmArray results were compared to conventional blood culture and susceptibility testing. One 250 µl aliquot from each PABC was simultaneously tested in a pouch with nested multiplexed PCR assays for gram positive and gram negative bacteria, fungi and antibiotic resistance genes.

PCRprimersaredriedintothewellsofthearrayandeachprimersetamplifiesauniqueproductofthefirst-stagemultiplexPCR.ThesecondstagePCRproductisdetectedinreal-timeusingafluorescent-double-strandedDNAbindingdye,LCGreen® Plus.